• PHP104 Potential Implications of National Disease Registries and Centers of Excellence for Orphan Diseases for Pharmaceutical Manufacturers Developing Orphan Drugs

    Jun 1, 2012, 00:00

  • PHP52 Root Cause Analysis of Discarded Drugs in Taiwan

    Jun 1, 2012, 00:00

  • PSS24 Patient-Reported Outcomes in a Dental Practice-Based Research Network-PEARL

    Jun 1, 2012, 00:00

  • PHP106 Priority Setting for Health Technology Assessment in Ukraine

    Jun 1, 2012, 00:00

  • PMH78 Economic Burden Associated with Extra-Pyramidal Symptoms in a Medicaid Population with Schizophrenia

    Jun 1, 2012, 00:00

  • PHP94 The US Orphan Drug Landscape- Before and After EU Orphan Drug Legislation of 2000

    Jun 1, 2012, 00:00

  • PND5 Budget Impact Analysis of Fingolimod for the Treatment of Multiple Sclerosis in Colombia

    Jun 1, 2012, 00:00

  • ISPOR 17th Annual International Meeting Research Abstracts Author Index

    Jun 1, 2012, 00:00

  • PSU17 Retrospective Data Analysis Assessing Hospital Costs and Resource Utilization Associated with Perioperative Blood Loss in Prostate Surgeries

    Jun 1, 2012, 00:00

  • PDB20 Estimated Prevalence of Hypoparathyroidism in the United States Using a Large Claims Database and Disease Severity From Primary Market Research

    Jun 1, 2012, 00:00

  • PMH50 Psychiatrists' Preferences for Attributes of Antipsychotic Medications to Treat Schizophrenia- A Conjoint Analysis

    Jun 1, 2012, 00:00

  • PRS45 A Large-Scale Retrospective Study of Emergency Department Visits or Hospitalizations for Anaphylaxis among Patients with Employer- Sponsored Health Insurance

    Jun 1, 2012, 00:00

  • PHP21 Complementary and Alternative Medicine Use Among People With Disabilities- NHIS 2007 Survey

    Jun 1, 2012, 00:00

  • PIH12 Budget Impact Analysis of Adding a New Fixed-Dose Combination Therapy of Dutasteride and Tamsulosin to the Treatment of Symptomatic Benign Prostatic Hyperplasia in Quebec, Canada

    Jun 1, 2012, 00:00

  • PCV15 Social Networks Help Control Hypertension

    Jun 1, 2012, 00:00

  • PCV7 Impact of Comorbidities on Risk of Cardiovascular Hospitalization among Patients with and Without Atrial Fibrillation

    Jun 1, 2012, 00:00

  • PRM15 Use of Centralized National Data to Estimate Costs of EPI at National Level. The Bolivian Case, 2007-2009

    Jun 1, 2012, 00:00

  • PMH61 Effects of Lisdexamfetamine Dimesylate Augmentation on Functional Outcomes in Adults with Partially or Fully Remitted Major Depressive Disorder

    Jun 1, 2012, 00:00

  • PRS29 Health Care Resource Utilization and Costs in Chronic Bronchitis Patients Treated with Copd Medications from a Managed Care Population in the United States

    Jun 1, 2012, 00:00

  • PDB105 Payor and Prescriber Feasibility Assessment of a Pharmacy Benefit Management (PBM) Diabetes Program Utilizing Pharmacist-Advised Self-Adjusted Basal Insulin

    Jun 1, 2012, 00:00

  • Copyright/Subscription

    Jun 1, 2012, 00:00

  • PCN126 Radiation After Breast-Conserving Surgery- Compliance of Clinical Guideline Among Young Women With Employment-Based Insurance in the United States

    Jun 1, 2012, 00:00

  • PND31 Assessing the Relationship Between the Number of Nursing Support Encounters and Medication Possession Ratio in Relapsing Remitting Multiple Sclerosis Patients Receiving Glatiramer Acetate

    Jun 1, 2012, 00:00

  • PCV92 Drug Approval Strategies in Germany

    Jun 1, 2012, 00:00

  • PCV86 Comparison of Charlson, Elixhauser and HRQoL-CI Risk Adjustment Measures in Predicting Health-Related Quality of Life in Heart Failure Patients

    Jun 1, 2012, 00:00

  • PIH51 Achievement of Cultural Equivalency when Translating a Patient-Reported Outcomes (PRO) Instrument Containing English-US IDIOMS and Colloqiualisms

    Jun 1, 2012, 00:00

  • PHP58 Effectiveness of Automated Telephonic Reminders on Medication Adherence

    Jun 1, 2012, 00:00

  • PCV100 Acute Heart Failure Patients with and Without Renal Impairment- A Study of Heart Failure-Related Resource Utilization and Costs in the United States

    Jun 1, 2012, 00:00

  • PMH30 The Societal Cost of Depression- Evidence from 10,000 Swedish Patients in Psychiatric Care

    Jun 1, 2012, 00:00

  • PIN18 Cost of Pneumococcal Diseases in Mexico With Patients Older Than 50 Years Old- A Micro-Costing Approach

    Jun 1, 2012, 00:00

  • PHP34 Eliciting Preferences for Reimbursed Drugs Selection Criteria in Cote d'Ivoire

    Jun 1, 2012, 00:00

  • PDB13 Short Stature in Turner Syndrome- Basal Characteristics and Follow-Up of a Colombian Cohort

    Jun 1, 2012, 00:00

  • PRM34 Estimating Markov Chain Transition Matrices in Limited Data Samples- A Monte Carlo Experiment

    Jun 1, 2012, 00:00

  • PGI29 Predictors of Nonpersistence and Nonadherence with Oral 5-Aminosalicylic Acid Therapy in Patients with Ulcerative Colitis

    Jun 1, 2012, 00:00

  • PIN24 Cost-Benefit Analysis of Hospital Based Postpartum Vaccination With Combined Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (TDAP)

    Jun 1, 2012, 00:00

  • HC4 CMS's Use of Cost-Effectiveness Evidence in NCDs for Prevention

    Jun 1, 2012, 00:00

  • PMD4 Qualitative Molecular Tests for Confirmation of the Diagnosis of Hepatitis C in Seropositive Patients- A Systematic Review

    Jun 1, 2012, 00:00

  • PDB34 Real-World Health Care Utilization, Productivity and Associated Costs Among Employees With Type 2 Diabetes Mellitus Treated With Insulin Glargine or Neutral Protamine Hagedorn (Nph) Insulin in the United States

    Jun 1, 2012, 00:00

  • PCV101 Hospitalizations and Primary Care Resource Use – A Real-Life Perspective

    Jun 1, 2012, 00:00

  • PCN41 Economic Burden Associated With Adverse Events in Patients With Metastatic Renal Cell Carcinoma

    Jun 1, 2012, 00:00

  • PSU33 Relationship Between Patient Characteristics and Discharge Destination Following Total Knee Arthroplasty (TKA)

    Jun 1, 2012, 00:00

  • PMD7 Long-Term Clinical Outcomes After Coronary Bare-Metal and Drug-Eluting Stenting

    Jun 1, 2012, 00:00

  • PCN6 Are Qaly Gains for New Pharmaceuticals Increasing in Cancer But Not Other Diseases?

    Jun 1, 2012, 00:00

  • PSS26 Determining Accurate Dosing of Ustekinumab from Specialty Pharmacy Data

    Jun 1, 2012, 00:00

  • PMS86 Use of Common Data Model to Enable Meaningful Comparison of Disease Burden among Disparate Databases

    Jun 1, 2012, 00:00

  • PRS17 Direct Incremental Costs of Chronic Obstructive Pulmonary Disease (Copd) and Asthma in the United States

    Jun 1, 2012, 00:00

  • PSU8 Disease Burden and Medical Needs in Older Patients with Total Knee Arthroplasties and Muscle Atrophy or Weakness

    Jun 1, 2012, 00:00

  • PHP7 Recent Developments in Pompe Disease Therapy

    Jun 1, 2012, 00:00

  • PUK28 Work Ability and Labor Supply After Kidney Transplantation

    Jun 1, 2012, 00:00

  • PDB87 Real-World Retrospective Analysis of Demographic Characteristics and Prevalence of Diabetes in Shanghai Minhang District

    Jun 1, 2012, 00:00

  • PDB45 Direct Medical Costs of Diabetes-Related Complications in Saudi Arabia

    Jun 1, 2012, 00:00

  • PRM20 Comparing the Use of Secondary Data Sources in Two Types of Journals During 2010

    Jun 1, 2012, 00:00

  • PMD21 Industrial-Grade Silicone in Breast Implants- Evaluating Cost Implications of Different Explantation Strategies

    Jun 1, 2012, 00:00

  • PIH70 Is Primary Care Accessible for the Poor in Mongolia?

    Jun 1, 2012, 00:00

  • PMS45 Parents' Preferences for Drug Treatments in Juvenile Idiopathic Arthritis- A Discrete Choice Experiment

    Jun 1, 2012, 00:00

  • MO2 The Cost-Effectiveness of Primary Stroke Centers for Acute Stroke Care

    Jun 1, 2012, 00:00

  • PCV104 Analysis of ARB and ACEI Consumption, Budget and Price Chance in Years for Turkey

    Jun 1, 2012, 00:00

  • PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer

    Jun 1, 2012, 00:00

  • PIH29 Adherence among Initiators and Switchers on Generic, Preferred and Non-Preferred Brand Therapies

    Jun 1, 2012, 00:00

  • PMH26 Modeling Economic Consequences of Cardiometabolic Changes with Lurasidone Versus Other Atypical Antipsychotics in Schizophrenia

    Jun 1, 2012, 00:00

  • PCN102 The Impact of Muscle Wasting or Weakness in Advanced Pancreatic Cancer Patients- Development of a Conceptual Model

    Jun 1, 2012, 00:00

  • PCV108 Measuring the Impact of Tobacco Control Policies on Health Outcomes Using the TOSCA (Tobacco Policy Outcomes and Smoking Cessation) Model

    Jun 1, 2012, 00:00

  • PCV63 Impact of Adherence to Statins and Antihypertensive Medications on Short-Term Disability Costs in an Employer Population

    Jun 1, 2012, 00:00

  • PMS28 Economic Evaluation of the Use of Anti TNF's and Tocilizumab for the Treatment of Systemic Juvenile Idiopathic Arthritis (sJIA) in Mexico

    Jun 1, 2012, 00:00

  • PMS55 Quality of Life among Patients with Self-Reported Rheumatoid Arthritis- A Nationally Representative Sample

    Jun 1, 2012, 00:00

  • PRM29 Comparison of Discrete Discounting and Non-Constant Exponential Discounting Approaches to Calcuate Future Gains in Quality-Adjusted Life-Years

    Jun 1, 2012, 00:00

  • PMD20 Estimated Cost Saving for Arthroscopic Subacromial Decompression

    Jun 1, 2012, 00:00

  • PDB76 Gap Analysis of Existing Diabetes-Specific Health-Related Quality of Life Measures for Use Among Multi-Ethnic English-Speaking Asians With Diabetes- An Interim Analysis

    Jun 1, 2012, 00:00

  • PR4 Breast Cancer Mortality Rates by Geographic Region, Years of Potential Life Lost, and Value of Productivity Losses among Women Aged 20-49 Years in the United States, 1970–2008

    Jun 1, 2012, 00:00

  • UT1 The Impact of Comparative Effectiveness Research on Drug Utilization in the United States

    Jun 1, 2012, 00:00

  • PDB23 Diabetic Ketoacidosis Gap Analysis. Population Perspectives From Lake County, IL, USA

    Jun 1, 2012, 00:00

  • PCV32 Health Resource Utilization of Patients with Chronic Thromboembolic Pulmonary Hypertension Versus Pulmonary Aterial Hypertension– Results of a Retrospective Study in Six European Countries

    Jun 1, 2012, 00:00

  • PUK2 Odds of Missed Hemodialysis Sessions are Increased During Holiday Periods among in-Center Hemodialysis Patients

    Jun 1, 2012, 00:00

  • PCV19 Venous Thromboembolism Prophylaxis and Clinical Consequences in Hospitalized Medically Ill Patients

    Jun 1, 2012, 00:00

  • PDB53 Cost-Effectiveness of Saxagliptin (Onglyza®) in Type 2 Diabetes in South Africa

    Jun 1, 2012, 00:00

  • PMS79 Patient Characteristics and Golimumab Utilization in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Patients

    Jun 1, 2012, 00:00

  • PIH3 Use of Mixed Treatment Comparison Methods in Estimating Efficacy of Treatments for Heavy Menstrual Bleeding

    Jun 1, 2012, 00:00

  • PIH35 Utilization and Adherence One-Year Post CDHP Implementation

    Jun 1, 2012, 00:00

  • PSS28 Intravitreal Injections in Austria - Results of an Expert Survey and Comparison with Utilisation Rates from the Austrian Ministry of Health

    Jun 1, 2012, 00:00

  • PCV46 Assessing the Cost-Effectiveness of the Recommended Antihypertensive Drug Classes in France Using a Lifetime Markov Model

    Jun 1, 2012, 00:00

  • PHP90 Case-Mix Adjustment of Adherence-Based Pharmacy Quality Indicator Scores

    Jun 1, 2012, 00:00

  • PSS19 Validation of the Paediatric Hearing Impairment Caregiver Experience (PHICE) Instrument

    Jun 1, 2012, 00:00

  • PCV61 Cost-Utility Analysis of Antihypertensive Medications in Nigeria Using a Decision Analytical Model

    Jun 1, 2012, 00:00

  • PCV37 Burden of Atrial Fibrillation Related Stroke in China

    Jun 1, 2012, 00:00

  • PCN145 Treatment Patterns and Outcomes Among Patients With Unresectable Stage III or Stage IV Melanoma in Mexico

    Jun 1, 2012, 00:00

  • PCV24 Congestive Heart Failure Gap Analysis. Population Perspectives from Lake County, IL, USA

    Jun 1, 2012, 00:00

  • PUK19 Incremental Cost-Effectiveness of Pharmacist-Managed Erythropoiesis-Stimulating Agents Clinics for Non-Dialysis Chronic Kidney Disease Patients

    Jun 1, 2012, 00:00

  • PHP8 A Review of Economic Evaluations on New Drugs Priced by the Cost Calculation Method in Japan. Can Japan go Beyond the Conventional Cost-Based Pricing?

    Jun 1, 2012, 00:00

  • PCN120 The Impact of Universal Health Insurance Coverage on Use of Medicines for Non-Communicable Diseases in Thailand

    Jun 1, 2012, 00:00

  • PMD34 Cost Effectiveness Model- Comparison of Closed Incision Management Using Negative Pressure and Standard of Care Over Clean Closed Incisions Based on a 2012 Randomized Controlled Trial

    Jun 1, 2012, 00:00

  • PCN124 FERPAC- A Practice Survey on the Administration of IV Iron Complexes on a Central Venous Access Port in Cancer Patients in France

    Jun 1, 2012, 00:00

  • MO4 Economic Evaluation of Treatment Strategies for Late-Presentation Acute Ischemic Stroke

    Jun 1, 2012, 00:00

  • PHP76 Effect of Technological Intervention on Work Efficiency at Intensive Care Unit

    Jun 1, 2012, 00:00

  • PMD6 The Clinical Usefulness of CT Coronary Angiography for the Diagnosis of Ischemic Heart Disease in Patients with Chest Pain

    Jun 1, 2012, 00:00

  • PCN49 Segmented Medical Costs of Squamous Cell Head and Neck Cancer- A Pharmacoeconomic Analysis Using a Private Insurance Database

    Jun 1, 2012, 00:00

  • PCN25 Effect of Treatments for Late-Stage Prostate Cancer on Survival

    Jun 1, 2012, 00:00

  • PHP79 Consistency Between Self-Reported and Recorded Values for Clinical Measures

    Jun 1, 2012, 00:00

  • PIN21 A Review of Economic Studies of Rubella and Rubella Vaccination

    Jun 1, 2012, 00:00

  • PMS5 Data Visualization of Treatment Patterns of Medicare Psoriatic Arthritis Patients Who Initiate Tumor Necrosis Factor Therapy

    Jun 1, 2012, 00:00

  • PDB88 Impact of Telephone and Mail Intervention on Diabetes Appointment Adherence Rates and Clinical Outcomes

    Jun 1, 2012, 00:00

  • PRS14 Cost-Effectiveness of Azithromycin and Clarithromycin Treatments for Community Acquired Pneumonia Requiring Hospitalization for Immunocompetent Individuals of Age 65 and Older, from Private Perspective in Brazil

    Jun 1, 2012, 00:00

  • PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

    Jun 1, 2012, 00:00

  • PMH83 Comparison of Total Health Care Costs Between Remitters and Non-Remitters for Schizophrenia Patients from a Prospective Longitudinal, Observational Study in the Presence of Missing Data

    Jun 1, 2012, 00:00

  • PCV41 Analysis of Direct Costs Associated with INR Monitoring and Warfarin Dose Ajustment in Patients with Atrial Fibrillation

    Jun 1, 2012, 00:00

  • PHP41 One-Year Assessment of Joint Procurement of Pharmaceuticals in the Public Health Sector in Jordan

    Jun 1, 2012, 00:00

  • PMS27 The Cost-Effectiveness of Denosumab for the Prevention of Osteoporotic Fractures in the Setting of the United States

    Jun 1, 2012, 00:00

  • PDB24 Prevalence and Incidence of Type 2 Diabetes Mellitus- An Analysis Based on 5.4 Million Patients

    Jun 1, 2012, 00:00

  • PCN128 Predictors of Non-Participation in a Surveillance Study of Appalachian Women Participating in a State-Wide Mobile Mammography Program

    Jun 1, 2012, 00:00

  • PSU28 Variables Associated with Length of Stay and ICU Need in Roux-en-Y Gastric Bypass Surgery for Morbid Obese Patients- A Cross-Sectional Study Based on the Public Health System Database (DATASUS) in Brazil

    Jun 1, 2012, 00:00

  • PCN24 Epidemiology of the Non-Hodgkin Lymphoma Colombia 2000-2011

    Jun 1, 2012, 00:00

  • PRM65 Prevalence-Based Versus Incidence-Based Economic Evaluations for the Assessment of New Health Care Interventions

    Jun 1, 2012, 00:00

  • IN1 Antibiotic Prescribing via Telephone- How Often Does it Occur?

    Jun 1, 2012, 00:00

  • PND52 Determining the Existence of Racial and Ethnic Disparities in Alzheimer's Disease Pharmacotherapy Exposure- An Analysis Across Four State Medicaid Populations

    Jun 1, 2012, 00:00

  • PIH56 Measuring Quality of Life in Facial Aesthetic Patients- Field-Testing of a New Modular System (the FACE-Q)

    Jun 1, 2012, 00:00

  • PDB67 Impact of Adherence to Oral Diabetes Medication on Short-Term Disability Costs in an Employer Population

    Jun 1, 2012, 00:00

  • PIH11 Prevalence and Incidence Rates of Most Common Comorbid Conditions among Patients with Tuberous Sclerosis Complex- A Naitonal Claim Database Analysis

    Jun 1, 2012, 00:00

  • PSY18 Economic Burden of Psoriasis (PSO) and Obesity in Patients With Psoriasis in the United States

    Jun 1, 2012, 00:00

  • PSY29 Lifetime Impact on Bleeding Episodes and Hospitalization of On-Demand Treatment Options in French Hemophilia Patients With Inhibitors

    Jun 1, 2012, 00:00

  • PMS6 Treatment Pattern Visualization of Medicare Patients Diagnosed with Rheumatoid Arthritis and Initiating Tumor Necrosis Factor Therapy

    Jun 1, 2012, 00:00

  • PMD51 National Trends in Advanced Diagnostic Imaging Use in Outpatient Settings- an Analysis of the Medical Expenditure Panel Survey, 2000-2009

    Jun 1, 2012, 00:00

  • PCN137 Surgery, Radiation, and Systemic Therapies in Patients With Metastatic Melanoma

    Jun 1, 2012, 00:00

  • PDB70 Health Utility for Patients With Tpye 2 Diabetes Mellitus in China

    Jun 1, 2012, 00:00

  • PCN123 Retrospective Study of Health Care Utilization and Costs in Women With Metastatic Breast Cancer (MBC) Receiving Lapatinib After Treament With Trastuzumab

    Jun 1, 2012, 00:00

  • PIH15 Application of Probabilistic Linkage- Compare Health Care Costs among Menopausal Women with Different Symptoms by Linking Women's Registry and Claims Database

    Jun 1, 2012, 00:00

  • DR3 Establishment of an Innovative Collaborative Between the Drug Safety and Effectiveness Network in Canada and ISPOR for Application and Development of Network Meta-Analysis

    Jun 1, 2012, 00:00

  • PMS87 Osteoarthritis in France the Cost of Ambulatory Care in 2010

    Jun 1, 2012, 00:00

  • MO1 New Concepts in Discrete Choice Preference Measurement- An Application to Drug Treatment for Juvenile Idiopathic Arthritis

    Jun 1, 2012, 00:00

  • PMH79 Medical Costs and Hospitalizations among Persons with Depression Treated with Adjunctive Atypical Antipsychotic Therapy

    Jun 1, 2012, 00:00

  • PRM12 Comparison of Two Approaches to Costing National Immunization Programs- Central Level Budgeting Versus Detailing Costing Exercises Using a Novel Provac EPI Costing Tool in Bolivia

    Jun 1, 2012, 00:00

  • PMH12 National Trends of Psychotropic Medication Use among Patients Diagnosed with Anxiety Disorders- Results from the Medical Expenditure Panel Survey 2004-2009

    Jun 1, 2012, 00:00

  • PMH22 Correlates of Dropout from Community-Based Methadone Maintenance Treatment Program in Indonesia

    Jun 1, 2012, 00:00

  • PDB39 The Cost of Complications Associated With Diabetes- A Retrospective Claims Database Study

    Jun 1, 2012, 00:00

  • RM4 A Systematic Review of Costs Associated With Prescription Opioid Risks

    Jun 1, 2012, 00:00

  • PSU22 Cost-Effectiveness Analysis of Video-Assisted Thoracic Surgery vs. Open Surgery for Patients with Newly Diagnosed Stage I Non-Small Cell Lung Cancer

    Jun 1, 2012, 00:00

  • PMH32 Impact of Second Generation Anti-Psychotics in Bipolar Patients and Schizophrenia Patients in Th California Medicaid Program

    Jun 1, 2012, 00:00

  • PMS16 Cost of Tumor Necrosis Factor Blocker Per Treated Psoriatic Arthritis Patient Using Drug Utilization Data from a US Managed Care Population

    Jun 1, 2012, 00:00

  • PUK12 Examining the Dosing Patterns and Costs of Epoetin Alfa and Darbepoetin Alfa among Hospital Inpatients with Chronic Kidney Disease Not on Dialysis

    Jun 1, 2012, 00:00

  • PND21 Cost-Effectiveness Analysis of Antiepileptic Drugs in the Treatment of Lennox-Gastaut Syndrome

    Jun 1, 2012, 00:00

  • PND22 Pharmacoeconomic Assessment of Natalizumab in the Treatment of Multiple Sclerosis

    Jun 1, 2012, 00:00

  • PCN148 The Use of Personalised Medicine in Cancer Trials

    Jun 1, 2012, 00:00

  • PCV38 Venous Thromboembolism- A Refined United States Cost Model with Long Term Attack Rates

    Jun 1, 2012, 00:00

  • PMH45 Utility Scores Associated with the World Health Organisation Drinking Risk-Level Classification in Alcohol Dependence

    Jun 1, 2012, 00:00

  • PCV5 Intra-Arterial Thrombolysis Versus Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke- A Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PSY22 Health Care Costs for Inflammatory Bowel Disease Patients who are Adherent Versus Non-Adherent With Infliximab Therapy

    Jun 1, 2012, 00:00

  • PIH72 Impact of Pharmacist Intervention on the Utilization of Teriparatide in Osteoporosis

    Jun 1, 2012, 00:00

  • PCV88 Evaluating Outcomes Related to Hypertension in Toledo-Lucas County Carenet Patients

    Jun 1, 2012, 00:00

  • PDB56 Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients With Type 2 Diabetes Failing Metformin Monotherapy

    Jun 1, 2012, 00:00

  • PSY36 Economic Evaluation of Pegvisomant for Active Acromegaly Patients who Failed Available Therapies in Brazil – Public Health Care System Perspective

    Jun 1, 2012, 00:00

  • PRM2 Network Meta-Analysis of Individual and Aggregate Level Data

    Jun 1, 2012, 00:00

  • PDB30 A Comparison of the Costs for Treating Central Precocious Puberty During the First Year With Leuprolide Acetate Injectible and Histrelin Acetate Implant

    Jun 1, 2012, 00:00

  • PIN41 Cost-Effectiveness of Vaccination Against Yellow Fever in Ghana

    Jun 1, 2012, 00:00

  • PSU18 Retrospective Data Analysis Assessing Hospital Costs and Resource Utilization Associated with Perioperative Blood Loss in Renal Surgeries

    Jun 1, 2012, 00:00

  • CV1 Differences in Processes and Outcomes of Care in Elderly Hypertensive Diabetic Patients With and Without Dementia

    Jun 1, 2012, 00:00

  • PGI27 Resource Use and Cost Determinants for Patients with Crohn'S Disease in a Polish Tertiary Hospital

    Jun 1, 2012, 00:00

  • PIH44 Predictive Factors of Pharmacy Satisfaction Using a National Level Data in South Korea

    Jun 1, 2012, 00:00

  • PHP82 Comparative Analysis of Diseases Prevalence Rates in General Ukrainian Population and Subpopulations of War Veterans and Chernobyl Victims

    Jun 1, 2012, 00:00

  • PCV79 Survey of Patients with Atrial Fibrillation on the Use of Warfari and Dabigatran

    Jun 1, 2012, 00:00

  • PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011

    Jun 1, 2012, 00:00

  • PCN28 Budget Impact Analysis of Everolimus for ER+, HER2- Metastatic Breast Cancer Patients in the United States

    Jun 1, 2012, 00:00

  • PRS32 Self-Reported Adherence to Inhaled Corticosteroids and Beliefs About Medicines in Asthma Patients- a Study from Emergency Room of a Chest Hospital in Delhi, India

    Jun 1, 2012, 00:00

  • PMS18 The Direct and Indirect Costs of Long Bone Fractures in a Working Age U.S. Population

    Jun 1, 2012, 00:00

  • PUK17 Economic Benefits of Slowing Progress to End Stage Renal Disease (ESRD) in Patients with Diabetes-Related Chronic Kidney Disease (DKD), Compared with Standard of Care (SOC)

    Jun 1, 2012, 00:00

  • PIN58 Hospital Outcomes and Costs of Care for Severe Sepsis- A Population-Based Study

    Jun 1, 2012, 00:00

  • PIH69 Willingness to Pay for Vasomotor Symptoms Treatment in Korea

    Jun 1, 2012, 00:00

  • PCV33 Study on Hospitalization Costs for Patients with Atrial Fibrillation Related Stroke in China

    Jun 1, 2012, 00:00

  • PMH18 Factors Associated with Real-World Inpatient Use of Long-Acting Atypical Antipsychotics

    Jun 1, 2012, 00:00

  • PSU7 Economic Burden of Obesity and the Impact of Bariatric Surgery on Health Care Costs and Utilization

    Jun 1, 2012, 00:00

  • PCN103 Variation in Health-Related Quality of Life by Age Among Patients With Chronic Lymphocytic Leukemia

    Jun 1, 2012, 00:00

  • PIN23 Cost of Diagnosis and Prevention of Congenital Cytomegalovirus Infection

    Jun 1, 2012, 00:00

  • PHP46 Design and Operational Challenges With Time and Motion (TM) Studies Run Alongside Clinical Trials

    Jun 1, 2012, 00:00

  • PCV52 Urapidil in Treatment of Hypertension Urgencies in the Russian Federation- Cost-Effectiveness Analysis

    Jun 1, 2012, 00:00

  • PMD10 The Role of Biomarkers in Lung Cancer Screening- A Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PIH41 Evaluating the Perception of General Public Towards the Role of Pharmacist in Health Care System of Pakistan

    Jun 1, 2012, 00:00

  • PHP73 Budget Impact Analysis- Do Canadian Guidelines Meet the Needs of Public Drug Plan Managers?

    Jun 1, 2012, 00:00

  • CN3 Multi-Level Modeling of Overall Mortality for Men Diagnosed With Prostate Cancer in Florida

    Jun 1, 2012, 00:00

  • PRM11 The Rise Of Budget Impact Analyses

    Jun 1, 2012, 00:00

  • PMS25 Economic Evaluation of Pharmacological Thromboprophylaxis in Hip Surgery Patients in Mexico

    Jun 1, 2012, 00:00

  • PMS20 Real Life Treatment Cost of Rheumatoid Arthritis, Psoriasis, Crohn's Disease and Ulcerative Colitis in the Brazilian Private Health Care System

    Jun 1, 2012, 00:00

  • PMH24 Differences in Health Care Utilization and Associated Costs Between Patients Prescribed Versus not Prescribed Opioids During an Inpatient or Emergency Department Visit

    Jun 1, 2012, 00:00

  • PIN20 Costs of Probable Bacterial Pneumonia in Children Under 5 Years Old in Colombia

    Jun 1, 2012, 00:00

  • PDB100 Health Care Utilization and Cost Patterns Among Diabetes Patients Prior to Initiation With Saxagliptin and Other (Non-Insulin) Antidiabetic Medications in a US Health Plan

    Jun 1, 2012, 00:00

  • PIH81 A Qualitative Study Evaluating Perceptions of Nurses Towards the Role of Pharmacist in Pakistan

    Jun 1, 2012, 00:00

  • PMS46 Patient Trade-Offs Between Frequency and Duration of Biologic Treatments for Rheumatoid Arthritis

    Jun 1, 2012, 00:00

  • PUK27 Validity and Reliability of KDQOL-36 in Thai Kidney Disease Patient

    Jun 1, 2012, 00:00

  • PSY12 A Budget Impact Analysis of Tapentadol Extended Release (ER) for the Treatment of Moderate to Severe Chronic Pain

    Jun 1, 2012, 00:00

  • PSS16 Systematic Review of Cost-Utility Analyses in Age-Related Macular Degeneration

    Jun 1, 2012, 00:00

  • PRM62 Visual Assessment of Fit of Equations to Predict Time-to-Event Outcomes

    Jun 1, 2012, 00:00

  • PHP78 Development of a New System for Registration of Patient Registries

    Jun 1, 2012, 00:00

  • PMS3 Comparative Effectiveness Analysis Using “Real-World” Patient Database to Evaluate the Fractures Rates Comparing Annual Zoledronic Acid Infusion with Oral Bisphosphonates

    Jun 1, 2012, 00:00

  • CE3 Grace Checklist- Rating the Strength of Evidence for Observational Studies of Comparative Effectiveness

    Jun 1, 2012, 00:00

  • PRM47 Bayesian Regression Models for Estimation of Illness-Attributable Cost from Aggregate Data

    Jun 1, 2012, 00:00

  • PSS32 Pharmacoeconomic Evaluation of Bacterial Eye Inflammation Treatment in Russia

    Jun 1, 2012, 00:00

  • PDB29 Budget Impact Analysis of Norditropin Versus Three Leading Market Growth Hormone Therapies

    Jun 1, 2012, 00:00

  • PMD8 Efficacy of Systemic Hyperbaric Oxygen Therapy for Non-Healing Diabetic Ulcers of the Lower Limb- Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PSY45 Examining Psoriasis Patient Perspectives of Disease and Treatment- A Novel Multi Discriminate Approach

    Jun 1, 2012, 00:00

  • PMS58 Burden of Disease in Patients with Diagnosed Rheumatoid Arthritis in Brazil- Results from 2011 National Health and Wellness Survey (NHWS)

    Jun 1, 2012, 00:00

  • PCN155 Patient Benefit-Risk Preferences for Advanced Renal Cell Carcinoma Treatments- Results From a Conjoint Analysis Study

    Jun 1, 2012, 00:00

  • PDB86 Evaluation of Pharmacists Time and Therapy Management for Patients With Type 2 Diabetes Served by a Rural Free Clinic

    Jun 1, 2012, 00:00

  • PCN36 Epoetin Alfa and Darbepoetin Alfa Dosing Patterns and Costs in Chemotherapy-Induced Anemia Inpatients

    Jun 1, 2012, 00:00

  • PCV84 A Comparison of Clinician and Patient Views on Symptoms and Impact of Post-Stroke Spasticity

    Jun 1, 2012, 00:00

  • PHP53 Recent Growth in Employer Health Care Spending by Disease- An Update

    Jun 1, 2012, 00:00

  • PSY28 Cost-Effectiveness Analysis of Celecoxib in the Treatment of Chronic Pain in Patients With Osteoarthritis or Rheumatoid Arthritis Versus the Use of Etoricoxib or Lumiracoxib in Mexico

    Jun 1, 2012, 00:00

  • PHP37 Are Hospital Inpatient Costs Lower for Medicare Advantage Enrollees Than Medicare Fee-for-Service Beneficiaries?

    Jun 1, 2012, 00:00

  • PMH33 Economic Evaluation of Agomelatine for Major Depressive Disorders in the Greek Setting

    Jun 1, 2012, 00:00

  • PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in Sweden

    Jun 1, 2012, 00:00

  • PND2 Dopamine Agonists and Dyskinesia in Advanced Parkinson's Disease- A Network Meta-Analysis of Rotigotine, Pramipexole and Ropinirole As Adjunct Therapy to Levodopa

    Jun 1, 2012, 00:00

  • PCN62 Cost-Effectiveness Analysis of First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia

    Jun 1, 2012, 00:00

  • MA3 Comparative Outcomes of Fibromyalgia Patients Who Initiated Duloxetine or Pregabalin- Medication Adherence and Direct Medical Costs

    Jun 1, 2012, 00:00

  • PMS31 Cost-Effectiveness Analysis of Golimumab for the Treatment of Rheumatoid Arthritis

    Jun 1, 2012, 00:00

  • PIN1 Outcomes Associated With Severe Comorbidities in Hospitalized Cases of HIV/AIDS

    Jun 1, 2012, 00:00

  • PMH62 Predominant Negative Symptoms in Schizophrenia

    Jun 1, 2012, 00:00

  • PUK36 Using Bootstrap Confidence Intervals to Compare Relative Validity Coefficients- an Example with PRO Measures of Chronic Kidney Disease (CKD) Impact

    Jun 1, 2012, 00:00

  • PIH52 Electronic Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM)- Case in Point Prostate Cancer

    Jun 1, 2012, 00:00

  • PMD59 Assessment of Administrative Data for Evaluating the Shifting Acquisition of Clostridium Difficile Infection in England

    Jun 1, 2012, 00:00

  • PSY41 Evaluating the Frequency and Sequence of Items Administered Using Promis Computer Adaptive Testing

    Jun 1, 2012, 00:00

  • PIH62 Over-the-Counter Medication Use and its Impact on Quality of Life of the Elderly

    Jun 1, 2012, 00:00

  • PCN105 Patient-Reported Outcomes (PROs) and Tolerability of Therapeutic Agents in Patients With Metastatic Prostate Cancer (MPC)- A Systematic Literature Review

    Jun 1, 2012, 00:00

  • PMH37 Cost-Effectiveness of Asenapine in the Treatment of Bipolar I Disorder in Canada

    Jun 1, 2012, 00:00

  • PCV50 Cost Effectiveness Analysis of Azilsartan Medoxomil and Chlorthalidone Fixed Dose Combination Therapy for Treatment of Hypertension

    Jun 1, 2012, 00:00

  • PHP74 Low Efficacy of Innovative Drugs as a Key Factor of Negative Recommendations Issued by Agency for Health Technology Assessment in Poland (AOTM) in 2011

    Jun 1, 2012, 00:00

  • PDB12 Comparative Effectiveness Study of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Type 2 Diabetes

    Jun 1, 2012, 00:00

  • PMH6 The Impact of Long-Acting Injectable Versus Oral Antipsychotics on Hospitalization Rates in Patients with Schizophrenia- A Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PCN133 Data Linkage for HPV Vaccination, Screening, and Cervical Cancer Outcomes- Is There an Evidence Base for Public Health Decision-Making on Cervical Cancer Prevention Strategies?

    Jun 1, 2012, 00:00

  • PCV72 Chronic Medication Adheren Its Association with Health Care Costs

    Jun 1, 2012, 00:00

  • PND41 Parkinson's Disease Questionnaire (PDQ-39) As a Primary Endpoint in a Trial Comparing Deep Brain Stimulation With Best Medical Therapy Versus Best Medical Therapy Alone for Advanced Parkinson's Disease (PD SURG TRIAL)- A Randomised, O ...

    Jun 1, 2012, 00:00

  • PMS91 Using Discrete Choice Experiments (DCE) to Estimate Preference-Based Utilities for Dupuytren's Contracture (DC)

    Jun 1, 2012, 00:00

  • PUK22 Comparison of Utility Score and Quality of Life Score in Thai Patient Between Twice and Thrice-Weekly Hemodialysis

    Jun 1, 2012, 00:00

  • PMS11 The Cost of Hospitalization of Hip Osteoarthritis Patients in France in 2010

    Jun 1, 2012, 00:00

  • PMS76 Two-Year Direct Health Care Cost Burden of Psoriatic Arthritis to Managed Care- A Retrospective Case Study of Golimumab Patients

    Jun 1, 2012, 00:00

  • PMH86 Time-on-Therapy for Atypical Antipsychotics in a Markov Cohort Analysis

    Jun 1, 2012, 00:00

  • PND27 Model of Rasagiline Versus Standard of Care for Parkinson's Disease- Comparison of Progression Effects

    Jun 1, 2012, 00:00

  • PCN151 Designing Case Report Forms for Economic Evaluation Along Side Clinical Trials- A Case-Study Using an Interactive Data Analysis Tool to Streamline Data Collection

    Jun 1, 2012, 00:00

  • PRM22 Comparison of Methods for the Evaluation of Ustekinumab Dosing and Costs in Pharmacy Claims Databases

    Jun 1, 2012, 00:00

  • PND49 Treatment for Patients Diagnosed With Parkinson's Disease- Differences Based Upon Diagnosing Physician

    Jun 1, 2012, 00:00

  • PCV64 Health Care Resource Utilization and Costs for Acromegaly- A Retrospective Study in a Large Claims Database in the United States

    Jun 1, 2012, 00:00

  • PDB95 A Descriptive Study of Opioid Use in the Management of Diabetic Peripheral Neuropathy (DPN) in a Large Commercially Insured Population

    Jun 1, 2012, 00:00

  • PND47 Rescue Medication Use in the Acute Treatment of Migraine During Map0004 Pivotal Trial

    Jun 1, 2012, 00:00

  • PHP92 Applying Actuarial Methodology to Hosptial Data for Estimation of Medical Errors

    Jun 1, 2012, 00:00

  • PRS22 Cost-Effectiveness of Indacaterol on Patients with Chronic Obstructive Pulmonary Disease (Copd) at the Public Mexican Health Care System

    Jun 1, 2012, 00:00

  • PDB14 Assessing Treatment Success of Diabetes Therapies - Number Needed to Treat to Reach a Clinically Relevant Composite Endpoint- Using a Meta-Analysis of the Liraglutide Clinical Trial Program

    Jun 1, 2012, 00:00

  • PCV55 Cost-Effectivness of Rosuvastatin Versus Ezetimibe/Simvastatin Fixed Combination in Reaching Cholesterol Goals for Mexican Patients

    Jun 1, 2012, 00:00

  • PHP65 Factors Influencing Reimbursement Price of New Drugs After Introduction of Positive List System

    Jun 1, 2012, 00:00

  • PRS47 Predictors of Willingness to Quit among a Cohort of Adult Smokers in India

    Jun 1, 2012, 00:00

  • PDB92 The Evolution of Oral Anti-Diabetes Medication Use in Taiwan (1999-2009)

    Jun 1, 2012, 00:00

  • PHP91 Factors Affecting Serum Potassium Measurements After Initiation of Spironolactone at an Academic Medical Center

    Jun 1, 2012, 00:00

  • PCV58 Cost-Effectiveness of Dronedarone in Non-Permanent Atrial Fibrillation in Turkey Compared to Standard Treatment, Amiodarone and Sotalol

    Jun 1, 2012, 00:00

  • PCV18 Evaluation of Response to Loading Doses of Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention (PCI)

    Jun 1, 2012, 00:00

  • PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian Perspectives

    Jun 1, 2012, 00:00

  • PHP111 Global Evidence Generation - Challenges for the Pharma Industry

    Jun 1, 2012, 00:00

  • PND55 Determinants of Prescription Drug Expenditures in Patients With Multiple Sclerosis- An Analysis of Medical Expenditure Panel Survey Data, 2002 - 2009

    Jun 1, 2012, 00:00

  • PMD45 Variation in Health Related Quality of Life Improvement After Percutaneous Coronary Intervention

    Jun 1, 2012, 00:00

  • PMD62 A Simulated Control Group Comparative Approach to Using Phase I Trial Data to Assess the Outcomes of a Novel Treatment for Acute Kidney Failure

    Jun 1, 2012, 00:00

  • PDB54 Saxagliptin or Sulfonylurea After Metformin Secondary Failure- a Cost-Effectiveness Analysis in Colombia

    Jun 1, 2012, 00:00

  • PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 Infection

    Jun 1, 2012, 00:00

  • PIH1 The Clinical Consequences of Exposure to Clinically Important Drug-Drug Interactions

    Jun 1, 2012, 00:00

  • PMD23 Health Care Utilization and Costs in Patients Experiencing Bone Fracture Nonunion

    Jun 1, 2012, 00:00

  • PMH74 Pattern of Antidepressants Utilization and Cost in Iran During 2007-2009

    Jun 1, 2012, 00:00

  • PMD50 Should Patients Be Allowed to Co-Pay for Devices and Technologies in the Future?

    Jun 1, 2012, 00:00

  • PMD36 The Use of Chlorhexidine Gluconate Impregnated Sponge Dressings to Prevent Central-Line Associated Bloodstream Infections and Local Site Infections in Canadian Hospitals- An Economic Analysis

    Jun 1, 2012, 00:00

  • PDB17 Using a Novel, Graphical Method to Analyze Complex Treatment Patterns For Patients With Acromegaly

    Jun 1, 2012, 00:00

  • PSU35 Cost of Unavailable Surgical Instruments in Australian Hospitals

    Jun 1, 2012, 00:00

  • PHP28 Access to Orphan Oncology Drugs in France Versus the United Kingdom

    Jun 1, 2012, 00:00

  • PSY65 Meta-Analysis of Health-Related Quality of Life Outcomes – Methods for Enhancing Interpretability of Findings

    Jun 1, 2012, 00:00

  • PMS12 Number Needed to Treat (NNT), Cost Per Responder (CPR) and Budget Impact (BI) of TNF Inhibitors (TNFi) in the Treatment of Psoriatic Arthritis (PSA)

    Jun 1, 2012, 00:00

  • PRM40 A Look At Previous and Current Methods Used to Collect Patient-Reported Outcomes Information

    Jun 1, 2012, 00:00

  • DR2 The Relationship Between Pseudoephedrine Sales and Clandestine Methamphetamine Labs

    Jun 1, 2012, 00:00

  • PND35 Fictitious Preferences or Felicitous Recoding? Conjoint Respondents Who Make Sense of Nonsensical Questions

    Jun 1, 2012, 00:00

  • PSY31 Economic Evaluation of Eletriptan 40mg for Migraine Therapy in Korea

    Jun 1, 2012, 00:00

  • Table of Contents

    Jun 1, 2012, 00:00

  • PRM54 A Conceptual Analysis of When Medical Expenditure Panel Survey (MEPS) Meets Cost of Illness (COI) – Are They a Match?

    Jun 1, 2012, 00:00

  • PSY49 Smoking Cessation Medication Use Among Adult Smokers With Various Body Weight Levels – an NHANES Study

    Jun 1, 2012, 00:00

  • PRS7 Cost Effectiveness and Utility Evaluation of Inhaled Corticosteroids among Asthma Patients at South India

    Jun 1, 2012, 00:00

  • PCV14 Are Vasodilators of Value in the Care of Patients Hospitalized for Acute Heart Failure?

    Jun 1, 2012, 00:00

  • PSS31 Analysis of the Relationship Betweenpsoriasis Severity and Quality of Life, Work Productivity, and Activity Impairment among Patients with Moderate to Severe Psoriasis Using Structural Equation Modeling

    Jun 1, 2012, 00:00

  • PCV94 Unpacking the Rapid Grwoth of Pharmaceutical Spending Growth- A Case Analysis of Chinese Hospital

    Jun 1, 2012, 00:00

  • CO2 Advancing the Methods of Cost-Effectiveness Analysis- Why It's Time to Move on from ICERs and Thresholds

    Jun 1, 2012, 00:00

  • PSY6 The Impact on Sleep Quality of Butrans® (Buprenorphine) Transdermal System 5 Mcg/Hour (BTDS 5) and 20 Mcg/Hour (BTDS 20) Dosages in Patients With Moderate-to-Severe Chronic Low Back Pain

    Jun 1, 2012, 00:00

  • DR1 Public Health Innovation- Biopharmaceuticals Lost in Translation?

    Jun 1, 2012, 00:00

  • PCN68 Cost-Effectiveness of HER-2-Positive Metastatic-Breast-Cancer Treatment in Post-Herceptin Progression in Colombia

    Jun 1, 2012, 00:00

  • PCN2 Depression Treatment in Individuals With Physical Illnesses- A Comparison Between Cancer and Cardio-Metabolic Conditions

    Jun 1, 2012, 00:00

  • PMH14 Predictors of Ambulatory Visit Utilization among Patients with Attention Deficit/Hyperactivity Disorder in the United States

    Jun 1, 2012, 00:00

  • PRM31 Evaluation of Decision Analytic Models in Cost-Effectiveness Analysis in Korea- From Guideline to Practice

    Jun 1, 2012, 00:00

  • PMD49 Do HTA Requirements and Procurement Incentives in Medical Devices Need Re-Aligning?

    Jun 1, 2012, 00:00

  • PCV97 Real World Patient Profile of Patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 Regions of China

    Jun 1, 2012, 00:00

  • PMH84 Validity of Administrative Claims Data for Calculating Adherence Measures for Long-Acting Injectable (Lai) Antipsychotic Therapies

    Jun 1, 2012, 00:00

  • PRM37 A Literature Review of Empirical Studies of Process Utility

    Jun 1, 2012, 00:00

  • PMS39 Long Term Medication Adherence of Adalimumab and Etanercept Among Rheumatoid Arthritis Patients in Kaiser Permanente Soutern California

    Jun 1, 2012, 00:00

  • PDB59 Cost-Effectiveness Analysis of Medication Therapy Management in Patients with Type 2 Diabetes in Community Pharmacy/Ambulatory Care Settings- Results From a Decision-Analytic Markov Model

    Jun 1, 2012, 00:00

  • PCV40 Evaluating Health Care Utiliization and Costs Associated with Blood Pressure Control in Patients with Newly Treated Hypertension

    Jun 1, 2012, 00:00

  • PCN135 Creating Oncology Coverage Policy- The Reliance on Compendia and Treatment Guidelines by 25 Private us Payer

    Jun 1, 2012, 00:00

  • PIH18 Regional Cost-Effectiveness Analysis of Universal Childhood Hepatitis a Vaccination in Brazil

    Jun 1, 2012, 00:00

  • PDB21 Preventative Steps Across Pre-Diabetic and Diagnosed Type 2 Diabetes Patients in Brazil

    Jun 1, 2012, 00:00

  • PMH34 Long-Term Cost-Effectiveness of Atypical Antipsychotics for Schizophrenia in the United States

    Jun 1, 2012, 00:00

  • PMD42 Cost-Effectiveness of Coflex® Interlaminar Stabilization Compared with Instrumented Posterior Spinal Fusion for Spinal Stenosis and Spondylolisthesis

    Jun 1, 2012, 00:00

  • PMS13 Medication Adherence and Health Care Costs among Patients with Osteoarthritis Initiating Duloxetine Versus Celecoxib

    Jun 1, 2012, 00:00

  • PIH27 Would Societal Costs in Health Economic Analyses Influence Decision Making? Hypothetical Analyses for Germany and France

    Jun 1, 2012, 00:00

  • PIH6 Antipsychotic Use and Risk of Nursing Home Admission among Community-Dwelling Dual Eligible Beneficiaries

    Jun 1, 2012, 00:00

  • PCN134 Effects of Clinical Pharmacist Interventions on Clinical Outcomes in Oncology Patients

    Jun 1, 2012, 00:00

  • PHP45 Burden of Illness of Chronic Conditions (CC) Among Hospitalized Patients- The Argentine-Health Care Cost and Utilization Project (A-HCUP)

    Jun 1, 2012, 00:00

  • PCN113 Patient Reported Outcomes in Oncology Clinical Trials- Are You Capturing the Linguistic Diversity of the Patient Population in India?

    Jun 1, 2012, 00:00

  • PIN62 Effectiveness of Text Message Reminders for Improving Vaccination Appointment Attendance and Series Completion Among Adolescents and Adults

    Jun 1, 2012, 00:00

  • PRS43 Comparisons of Patient Characteristics and Health Care Costs by Quartile among Patients with Allergic Rhinitis

    Jun 1, 2012, 00:00

  • PIH67 Associations between Wellness Coaching and Changes in Health-Related Quality of Life

    Jun 1, 2012, 00:00

  • PIH16 Cost-Effectiveness of a New Fixed-Dose Combination of Dutasteride and Tamsulosin for the Treatment of Symptomatic Benign Prostatic Hyperplasia in Quebec, Canada

    Jun 1, 2012, 00:00

  • PRS13 A Budget Impact Analysis of Indacaterol for the Treatment of Chronic Obstructive Pulmonary Disease in Colombia

    Jun 1, 2012, 00:00

  • PIN22 Economic Burden of Hospitalization With Antibiotic Treatment for Absssi in the United States- An Analysis Ofthe Premier Hospital Database

    Jun 1, 2012, 00:00

  • PIN50 How to Select Patient-Reported Outcome (PRO) Measures to Ensure Proper Evaluation of an Observational Study

    Jun 1, 2012, 00:00

  • PSS9 Economic Burden of Wet Age-Related Macular Degeneration (WAMD) in Urban China

    Jun 1, 2012, 00:00

  • PSY40 Are Neuropathic Pain (NP) Treatment Benefits Reflected in the Self Assessment of Treatment (SAT) Questionnaire?

    Jun 1, 2012, 00:00

  • PHP69 Trends of Emergency Room Visits Versus Hospitalizations Due to Unintentional Poisonings in Kansas City, Missouri

    Jun 1, 2012, 00:00

  • PRM59 Trade-Off Analysis- an Extension of Threshold Pricing Analysis

    Jun 1, 2012, 00:00

  • PMS50 Benefits in Patient Reported Outcomes Supporting a “Treat to Target” Paradigm for Infliximab -Treated RA Patients Previously Inadequately Responsive to Prior Anti-TNF Treatment

    Jun 1, 2012, 00:00

  • PRM60 Operationalising Multiple Criteria Decision Analysis for Health Technology Assessment

    Jun 1, 2012, 00:00

  • PSS3 Using Data Visualization to Illustrate Treatment Patterns of Medicare Patients with Diagnosis of Psoriasis Who Initiated Tumor Necrosis Factor Therapy

    Jun 1, 2012, 00:00

  • PSY23 Burden of Illness of Aggressive Systemic Mastocytosis (ASM) in the United States

    Jun 1, 2012, 00:00

  • PRM43 Robustness of Confidence Intervals for Rare Events

    Jun 1, 2012, 00:00

  • PSY32 Cost- Effectiveness Analysis of Parecoxib in the Management of Postsurgical Pain in Mexico

    Jun 1, 2012, 00:00

  • PDB26 Factors Associated With Three Years of Good or Poor Hemoglobin A1C Control Among Patients With Diabetes

    Jun 1, 2012, 00:00

  • PMH1 Pharmacotherapy and Associated Outcomes in Pediatric Bipolar Depression

    Jun 1, 2012, 00:00

  • PGI8 Prevalence of Gastroprotective Agent Use Among Adults with Arthritis Taking NSAIDS

    Jun 1, 2012, 00:00

  • PIH32 Demographic and Health Characteristics Associated with Intentional and Unintentional Non-Adherence among Costly Chronic Conditions in the United States

    Jun 1, 2012, 00:00

  • PSS18 Comparison of a 24-Hour and 7-Day Version of a Patient Reported Outcome Measure for Psoriasis Symptom Severity

    Jun 1, 2012, 00:00

  • PMS21 Mapping Health Care Costs to Clinical Disease Activity Where Cost Data is Lacking – A Novel Approach Using Medical Expenditure Panel Survey Data with the Corrona Rheumatoid Arthritis Disease Registry

    Jun 1, 2012, 00:00

  • PSS25 Actinic Keratosis Patients are Willing to Pay for Shorter Treatment and Local Skin Response Duration and Ingenol Mebutate Gel is Likely to Increase Patient Likelihood of Successful Completion of Topical Treatment

    Jun 1, 2012, 00:00

  • PCN132 A NHS Perspective of the Impact of the Cancer Drugs Fund on Oncology Drug Use and Other Health Care Resources Within England

    Jun 1, 2012, 00:00

  • PND7 Budget Impact and Cost-Effectiveness of Once-Daily Gabapentin for the Treatment of Postherpetic Neuralgia

    Jun 1, 2012, 00:00

  • PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in Mexico

    Jun 1, 2012, 00:00

  • PIN55 Anti-Malarial Drugs Management in Public and Private Secondary Health Care Facilities- A Comparative Cross Sectional Study from Pakistan

    Jun 1, 2012, 00:00

  • PND30 Health Care Resource Utilization and Quality of Life in Patients With Overactive Bladder Due to Neurogenic Detrusor Overactivity in the United Kingdom- A Database Analysis

    Jun 1, 2012, 00:00

  • PUK18 Cost-Effectiveness of Pharmacologic Treatment of Overactive Bladder

    Jun 1, 2012, 00:00

  • PIH59 Patient-Reported Outcomes- The Grounded Item Technique for Generating Content Valid Questions

    Jun 1, 2012, 00:00

  • PMH15 Trends in Prevalence of ADHD Drug Treatment in the Netherlands from 2000 Until 2010

    Jun 1, 2012, 00:00

  • PCV16 Dynamic Changes and Lifetime Scores for Different Items Measured by WHOQOL-BREF for Patients with Different Types of Ischemic Stroke

    Jun 1, 2012, 00:00

  • PDB5 Efficacy and Safety of Liraglutide 1.2Mg and Exenatide 10Mcg Twice Daily in Type 2 Diabetes Mellitus- A Systemtic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PMS19 Impact of Disease Severity on the Total, Health-Related, Financial Costs of Treatment of People with Rheumatoid Arthritis in the United Kingdom

    Jun 1, 2012, 00:00

  • PUK30 Once Monthly Erythropoiesis Stimulating Agent (ESA) Dosing May Reduce ESA Utilization Compared to Thrice-Weekly ESA Dosing

    Jun 1, 2012, 00:00

  • PMH56 Functioning and Quality of Life in Patients with Bipolar Disorder- Results from the Multinational Longitudinal WAVE-BD Study

    Jun 1, 2012, 00:00

  • PMH54 Using Longitudinal Data to Explain the Impact of Pain on Depression for General Population

    Jun 1, 2012, 00:00

  • PSY68 Preferences for Immunoglobulin Treatment Administration Attributes by Patients and Parents

    Jun 1, 2012, 00:00

  • PHP108 Analyzing the New Era of National Coverage Determinations (NCD'S) by the Centers for Medicare Medcaid Services (CMS) Post its Sipuleucel-T Decision

    Jun 1, 2012, 00:00

  • PHP39 The “Weight” of Orphan Drugs in the European Pharmaceutical Policy. A Focus on the Expenditure and the Utilization of Orphan Drugs in Five European Union Countries

    Jun 1, 2012, 00:00

  • PSY24 Association of Patient Cost or Reimbursement Challenges With Health Care Resource Utilization, Quality of Life, and Work Productivity Among Patients With Inflammatory Bowel Disease

    Jun 1, 2012, 00:00

  • PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF)- Russian Payer Perspective

    Jun 1, 2012, 00:00

  • PCN7 Life Expectancies and Prognostic Factors of Survival in Patients With Different Types of Cancer Under Prolonged Mechanical Ventilation- A Nation-Wide Analysis of 5,138 Cases During 1998-2007

    Jun 1, 2012, 00:00

  • PCV56 Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation Under the Private and Public Health Care System in Brazil

    Jun 1, 2012, 00:00

  • PHP56 An Analysis of Internal Medication Errors Using Incident Reports at a Teaching Hospital in Japan- A Retrospective Study

    Jun 1, 2012, 00:00

  • PDB7 Efficacy and Safety of Liraglutide 1.2Mg Once Daily in Type 2 Diabetes Mellitus- A Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PSY53 Evaluation of Daily Average Consumption (DACON) of Oxycodone CR and Oxymorphone ER Using an Interrupted Time Series Analysis

    Jun 1, 2012, 00:00

  • PCN58 A Comprehensive Cost-Effectiveness Analysis of Lenalidomide for Multiple Myeloma Patients who Have Received at Least One Prior Therapy

    Jun 1, 2012, 00:00

  • PSY66 Use of Medicaid Analytic Extract for Evaluation of Drug Use and Health Services Utilization in Patients With Hemophilia

    Jun 1, 2012, 00:00

  • PMH20 Factors Associated with Higher Health Care Resource Use among Patients with Bipolar Disorder- Results from a Large Multinational Longitudinal Study (WAVE-BD)

    Jun 1, 2012, 00:00

  • PHP70 E-Prescribing Trends in the United States- 2008-2012

    Jun 1, 2012, 00:00

  • PRM50 Meta-Regression Models to Address Heterogeneity and Inconsistency in Network Meta-Analysis of Survival Outcomes

    Jun 1, 2012, 00:00

  • PGI28 Proton Pump Inhibitor (Ppi) Prescribing Patterns, Ppi Costs, and Resource Utilization in a Nationally Representative Sample of Patients with Gastroesophageal Reflux Disease (GERD)

    Jun 1, 2012, 00:00

  • PMD18 Bypass Therapy Assay Testing As a Strategy to Reduce Treatment Costs for Hemophilia Patients with Inhibitors

    Jun 1, 2012, 00:00

  • PGI14 Resource Utilization in Thrombocytopenia of Chronic Liver Diseases in the Veterans Affairs Population

    Jun 1, 2012, 00:00

  • PCV23 Prevalence and Incidence of Atrial Fibrillation- An Analysis Based on 8.3 Million Patients

    Jun 1, 2012, 00:00

  • PCV110 Pharmacoeonomic Evaluation of Secondary Prophylaxis of Acute Coronary Syndrome by Statins in Ukraine

    Jun 1, 2012, 00:00

  • PDB111 Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions- A Case Study in Type 1 Diabetes

    Jun 1, 2012, 00:00

  • PCN71 Cost Effectiveness Analysis of Busulfan + Cyclophosphamide (BuCy2) as Conditioning Regimen Before Allogeneic Human Steam Cell Transplantation (HSCT)- Comparison of Oral Versus IV Busulfan

    Jun 1, 2012, 00:00

  • PIN17 Cost of Treatment Failure Among Adult Outpatients With Moderate or Complicated Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Skin Infections- A Starnet Study

    Jun 1, 2012, 00:00

  • PND56 Managed Care and Physician Perceptions of Novel Treatments in Multiple Sclerosis

    Jun 1, 2012, 00:00

  • PMD13 Assessing the Budget Impact of Using ScanBag® in CT in Six European Countries

    Jun 1, 2012, 00:00

  • PHP36 Comprehensive Value Estimation of Adalimumab-Based Treatments- Covet Study

    Jun 1, 2012, 00:00

  • PCV93 Market Response to Food and Drug Administration'S Safety Warnings- A Case Study Using an Interrupted Time Series Analysis of the Medicare Database for 2006-2008

    Jun 1, 2012, 00:00

  • IN3 Translating Outcomes from a Dynamic Transmission Model for Varicella Vaccination to Cost-Effectiveness Estimates- The Impact of Different Analytic Approaches on the Results

    Jun 1, 2012, 00:00

  • PRS40 Measurement of Primary Medication Adherence among Children with Asthma Using Administrative Claims Data

    Jun 1, 2012, 00:00

  • PUK7 Safety of Erythropoiesis-Stimulating Agents in Pediatric Patients with End Stage Renal Disease

    Jun 1, 2012, 00:00

  • PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes

    Jun 1, 2012, 00:00

  • PCV65 Service Utilization, Predictors and Costs among High-Risk Patients with Cardiovascular Disease- Using Real World Data from the Australian Reach Registry

    Jun 1, 2012, 00:00

  • PCV74 The Relationship Between Hospital Readmission and Post-Discharge Medication Adherence

    Jun 1, 2012, 00:00

  • PGI7 Factors Associated with Breakthrough Symptoms and OTC Use Among Gerd Patients in a Real-World Setting

    Jun 1, 2012, 00:00

  • PMH5 Association Between Second Generation Antipsychotics and Changes in Body Mass Index in Adolescents

    Jun 1, 2012, 00:00

  • PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated Disease

    Jun 1, 2012, 00:00

  • CE2 Comparative Effectiveness of Monotherapy With Mood Stabilizers Versus Atypical Antipsychotics for the Treatment of Bipolar Disorder in Children and Adolescents- A Retrospective Claims-Data Study

    Jun 1, 2012, 00:00

  • PRM13 Sensitivity Analysis in Cost-Effectiveness Analysis in Korea- A Review of Industry Submissions to HIRA

    Jun 1, 2012, 00:00

  • PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health Institutions

    Jun 1, 2012, 00:00

  • PSY35 Economic Evaluation of Lenalidomide in the Management of Previously Treated Multiple Myeloma (PTMM) Patients in Greece

    Jun 1, 2012, 00:00

  • PUK24 Examining the Role of Caregiver Towards Blood Transfusion Decisions among Individuals with Chronic Kidney Disease

    Jun 1, 2012, 00:00

  • PRM26 Access to Real-World Databases in Europe – How to Find the One That Will Answer Your Research Question?

    Jun 1, 2012, 00:00

  • PCV89 Patient-, Hospital-, and County- Level Predictors of Discharges and Readmissions among Patients with Cardiovascular Disease

    Jun 1, 2012, 00:00

  • PMS30 Cost-Effectiveness of Bisphosphonates in Reducing Hip Fractures in the United States

    Jun 1, 2012, 00:00

  • PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism- Analysis Based on Patient Reported Outcomes fro ...

    Jun 1, 2012, 00:00

  • PIH47 Symptoms and Management of Teething- Parents Reported Outcomes

    Jun 1, 2012, 00:00

  • UT3 Firm- and Drug-Specific Patterns of Generic Drug Prices Experienced by United States Medicaid Programs- 1991-2008

    Jun 1, 2012, 00:00

  • PCN34 Descriptive Costs of Chemotherapy Treatment for Stage 3 and Stage 4 Colon Cancer

    Jun 1, 2012, 00:00

  • HC2 Association of Allergic Rhinitis with Asthma Exacerbations and Health Care Costs in Asthma Patients

    Jun 1, 2012, 00:00

  • PND53 Discrepancies in Hospitalization Trends by Epilepsy Among Three Latin America Countries

    Jun 1, 2012, 00:00

  • PRM56 Modeling the Progression of Chronic Diseases in a Dynamic Market- Implications for Budget Impact Analysis

    Jun 1, 2012, 00:00

  • SB2 Comparative Effectiveness of On-Pump and Off-Pump Coronary Artery Bypass Grafting Among Elderly Patients – a Retrospective Analysis of Medicare Claims Data

    Jun 1, 2012, 00:00

  • PMS15 Cost Analysis of Febuxostat Versus Allopurinol for Prophylaxis of Gout Flares

    Jun 1, 2012, 00:00

  • PRM48 Diagnostic Tools for the Assessment of the Underlying Model Assumptions in the Study of Health Care Costs

    Jun 1, 2012, 00:00

  • PIH83 Health Technology Assessment in Child Health

    Jun 1, 2012, 00:00

  • PGI17 Societal Burden in Patients with Liver Transplantation- The Come Study Results

    Jun 1, 2012, 00:00

  • PSS12 Economic Analysis of Etanercept as Continuous or Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in Venezuela

    Jun 1, 2012, 00:00

  • PMS49 Fatigue is an Independent Variable Predicting Physical Function and Das-28 Remission for Patients with Rheumatoid Arthritis Treated with Intravenously Administered Golimumab- Results from a Phase 3, Placebo Controlled Clinical Trial

    Jun 1, 2012, 00:00

  • PDB83 Diabetes Medication Usage Patterns in Geographies With High Hispanic Populations in the United States

    Jun 1, 2012, 00:00

  • PMH35 Cost-Effectiveness of Agomelatine in Treatment of Major Depressive Disorders in Turkey

    Jun 1, 2012, 00:00

  • PMD15 The Economic Burden of Atrial Fibrillation among Elderly Populations in Selected Developed Countries

    Jun 1, 2012, 00:00

  • PCV67 Pharmacy Cost Sharing, Antiplatelet Therapy Utilization, and Health Outcomes for Patients with Acute Coroncary Syndrome

    Jun 1, 2012, 00:00
  • «
  • 131
  • 132 (current)
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »